Literature DB >> 8509855

Plasma D-dimer: a useful tool for evaluating suspected pulmonary embolus.

K A Harrison1, W D Haire, A A Pappas, G L Purnell, S Palmer, K P Holdeman, L M Fink, G V Dalrymple.   

Abstract

Although ventilation-perfusion lung scanning is widely used in evaluating patients with suspected pulmonary embolus, additional rapid screening tests are needed to supplement scintigraphy in patients in whom the scan is indeterminate or the scan results are discordant with clinical suspicion. D-dimer is a fibrin degradation product which should be elevated in the presence of intravascular coagulation. We prospectively studied patients referred for lung scanning by obtaining a plasma D-dimer latex agglutination assay at the time of the scan. Of 64 patients who had pulmonary angiography to confirm the diagnosis, 16 were positive for pulmonary embolus and only one had a normal D-dimer. The D-dimer was normal in 27 of 48 patients without embolus and elevated in 21. Although an elevated D-dimer level is a nonspecific finding, we conclude that a normal D-dimer is a good negative predictor for pulmonary embolus, with a negative predictive value of 0.97.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509855

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

Review 1.  Role of fibrin D-dimer testing in emergency medicine.

Authors:  A Wakai; A Gleeson; D Winter
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

Review 2.  D-dimer testing: the role of the clinical laboratory in the diagnosis of pulmonary embolism.

Authors:  B H Mavromatis; C M Kessler
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

3.  Is D-dimer a predictor of strangulated intestinal hernia?

Authors:  Gokhan Icoz; Ozer Makay; Murat Sozbilen; Baris Gurcu; Cemil Caliskan; Ozgur Firat; Zahide Kurt; Sinan Ersin
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

4.  The diagnostic value of D-dimer, procalcitonin and CRP in acute appendicitis.

Authors:  Bulent Kaya; Baris Sana; Cengiz Eris; Koray Karabulut; Orhan Bat; Riza Kutanis
Journal:  Int J Med Sci       Date:  2012-11-13       Impact factor: 3.738

5.  Silent venous thromboembolism before treatment in endometrial cancer and the risk factors.

Authors:  T Satoh; K Matsumoto; K Uno; M Sakurai; S Okada; M Onuki; T Minaguchi; Y O Tanaka; S Homma; A Oki; H Yoshikawa
Journal:  Br J Cancer       Date:  2008-09-09       Impact factor: 7.640

6.  High incidence of silent venous thromboembolism before treatment in ovarian cancer.

Authors:  T Satoh; A Oki; K Uno; M Sakurai; H Ochi; S Okada; R Minami; K Matsumoto; Y O Tanaka; H Tsunoda; S Homma; H Yoshikawa
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

7.  High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension.

Authors:  Manabu Sakurai; Toyomi Satoh; Koji Matsumoto; Hiroo Michikami; Yuko Nakamura; Sari Nakao; Hiroyuki Ochi; Mamiko Onuki; Takeo Minaguchi; Hiroyuki Yoshikawa
Journal:  Int J Gynecol Cancer       Date:  2015-05       Impact factor: 3.437

8.  Risk factors for venous thromboembolism induced by prolonged bed rest during interstitial brachytherapy for gynecological cancer: a retrospective study.

Authors:  Keiko Nemoto Murofushi; Tetsuya Tomita; Kayoko Ohnishi; Kei Nakai; Azusa Akiyama; Tsukasa Saida; Toshiyuki Okumura; Katsuyuki Karasawa; Toyomi Satoh; Hideyuki Sakurai
Journal:  Radiat Oncol       Date:  2021-06-29       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.